1.
Intraocular Peak Pressure in Patients Under Treatment With Fixed Combination of Bimatoprost/Timolol/Brimonidine Once Daily Versus Twice Daily.
Susanna Bianca N, Susanna Carolina N, Susanna Fernanda N, Mota Rodrigo T, Barbosa Gabriel C S, Lima Vagner L et al.
J GlaucomaMay 20223 citationsRandomized Controlled Trial
This study found that a triple-combination glaucoma medication (bimatoprost/timolol/brimonidine) was more effective at reducing peak eye pressure when used once daily compared to twice daily, suggesting improved efficacy with less frequent dosing.